-
Clinical Endpoints Study for NETHERTON SYNDROME
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for NEURODERMATITIS
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for NEUROFIBROMATOSES
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for NEVUS OF OTA
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for NEVUS, SEBACEOUS OF JADASSOHN
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for OCCUPATIONAL DERMATITIS
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for ONCHOCERCIASIS
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for ONYCHOLYSIS
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for ONYCHOMYCOSIS
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for ORBITAL CELLULITIS
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for PACHYONYCHIA CONGENITA
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for PAGET'S DISEASE, MAMMARY
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for PALMOPLANTAR PUSTULOSIS
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for PANNICULITIS
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for PAPILLON LEFEVRE DISEASE
Regular price From €900,00 EURRegular priceUnit price per -
Clinical Endpoints Study for PARAKERATOSIS
Regular price From €900,00 EURRegular priceUnit price per
Explore our exclusive study series
-
Safety Shield Studies
Safety Shield uses AI to streamline pharmacovigilance, reducing specialist workload by 80%...
-
Expert Mapping Studies
Expert Mapping Reports cut screening time by 10 days and reduce failed...
-
Clinical Endpoints Studies
This targeted analysis delivers a robust assessment of clinical endpoints tailored to...
